Release 93 (3), 293300
NO-releasing agents, such as JS-K ( O 2 -(2,4-dinitrophenyl)-1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate) 123 and PABA/NO ( O 2 -[2,4-dinitro-5-( N -methyl- N -4 carboxyphenylamino)phenyl] 1- N , N -dimethylamino)diazen-1-ium-1,2-diolate) 124 , are able to induce differentiation and cell death in a variety of cancer cells through GSH consumption, DNA synthesis inhibition and inhibition of enzymes involved in the defense against cell damage
Within this period re-treat with a non-selenised Vitamin B12 supplement DO NOT use at the same time as any other selenised fertiliser, prill or product without consulting a veterinarian Seek veterinary advice if poor stock condition persists after treatment Milk and Meat NIL READ ENTIRE LABEL BEFORE USE May be harmful if swallowed
However, the compound became widely available for routine use in the treatment of B12 deficiency in the early 1950s (8)
It is presently accepted that genetic susceptibility, environmental factors, including nutritional factors and immune disorders contribute to the development of AITD
GHK-Cu (Skin Glow) GHK-Cu (Skin Glow) GHK-Cu
